Gardner Lewis Asset Management L P Makes New $797,000 Investment in UnitedHealth Group Incorporated (NYSE:UNH)

Gardner Lewis Asset Management L P purchased a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 1,575 shares of the healthcare conglomerate's stock, valued at approximately $797,000.

A number of other institutional investors have also added to or reduced their stakes in UNH. NewSquare Capital LLC purchased a new position in UnitedHealth Group during the 4th quarter valued at about $25,000. AlphaMark Advisors LLC bought a new stake in UnitedHealth Group in the fourth quarter worth $30,000. Promus Capital LLC purchased a new stake in UnitedHealth Group during the 4th quarter valued at about $32,000. RPg Family Wealth Advisory LLC purchased a new position in UnitedHealth Group in the third quarter worth about $37,000. Finally, Pillar Financial Advisors LLC purchased a new position in UnitedHealth Group in the 4th quarter worth approximately $40,000. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Price Performance

UnitedHealth Group stock traded down $0.25 during mid-day trading on Friday, hitting $515.47. The stock had a trading volume of 2,378,211 shares, compared to its average volume of 4,268,981. The firm's 50 day moving average is $508.81 and its 200 day moving average is $544.24. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The firm has a market capitalization of $471.51 billion, a P/E ratio of 33.26, a P/E/G ratio of 1.37 and a beta of 0.62. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

Remove Ads

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the prior year, the company posted $5.83 EPS. The firm's revenue for the quarter was up 6.8% compared to the same quarter last year. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.63%. UnitedHealth Group's dividend payout ratio is currently 54.19%.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of research analyst reports. Piper Sandler lowered their price target on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a report on Thursday, January 2nd. Truist Financial reduced their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating for the company in a research note on Monday, January 6th. Wells Fargo & Company dropped their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating on the stock in a report on Tuesday, January 28th. Deutsche Bank Aktiengesellschaft raised their price target on UnitedHealth Group from $595.00 to $625.00 and gave the stock a "buy" rating in a research note on Tuesday, December 3rd. Finally, KeyCorp reissued an "overweight" rating and issued a $650.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Twenty investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Buy" and an average price target of $629.32.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the firm's stock in a transaction dated Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now owns 4,500 shares of the company's stock, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.